Published 4 years ago • loading... • Updated 4 years ago
Pfizer CEO sees annual COVID vaccine rather than frequent boosters
Summary by Ground News
Pfizer/BioNtech's COVID-19 vaccine has shown to be effective against severe disease and death caused by the heavily-mutated Omicron variant. With cases soaring, some countries have expanded vaccine booster programmes. Pfizer could be ready to file for approval for a redesigned vaccine, and mass produce it, as soon as March.